Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;103:1359-1362
Published online before print November 6, 2008, doi: 10.1161/CIRCRESAHA.108.186577
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
103/12/1359    most recent
CIRCRESAHA.108.186577v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitchell-Jordan, S. A.
Right arrow Articles by Vondriska, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitchell-Jordan, S. A.
Right arrow Articles by Vondriska, T. M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
Related Collections
Right arrow Animal models of human disease
Right arrow Cell signalling/signal transduction
Right arrow Hypertrophy
(Circulation Research. 2008;103:1359.)
© 2008 American Heart Association, Inc.


Reports

Loss of Bmx Nonreceptor Tyrosine Kinase Prevents Pressure Overload–Induced Cardiac Hypertrophy

Scherise A. Mitchell-Jordan, Tanja Holopainen, Shuxun Ren, Sujing Wang, Sarah Warburton, Michael J. Zhang, Kari Alitalo, Yibin Wang, Thomas M. Vondriska

From the Departments of Anesthesiology (S.A.M.-J., S.R., S. Wang, S. Warburton, M.J.Z., Y.W., T.M.V.), Medicine/Cardiology (Y.W., T.M.V.), and Physiology (Y.W., T.M.V.), David Geffen School of Medicine at the University of California, Los Angeles; and Molecular/Cancer Biology Laboratory (T.H., K.A.), Biomedicum Helsinki, the Haartman Institute and Helsinki University Hospital, University of Helsinki, Finland.

Correspondence to Thomas M. Vondriska, PhD, Departments of Anesthesiology, Medicine & Physiology, BH 557A CHS, 650 Charles Young Dr, UCLA, Los Angeles, CA 90095. E-mail tvondriska{at}mednet.ucla.edu

Abstract

Bmx nonreceptor tyrosine kinase has an established role in endothelial and lymphocyte signaling; however, its role in the heart is unknown. To determine whether Bmx participates in cardiac growth, we subjected mice deficient in the molecule (Bmx knockout mice) to transverse aortic constriction (TAC). In comparison with wild-type mice, which progressively developed massive hypertrophy following TAC, Bmx knockout mice were resistant to TAC-induced cardiac growth at the organ and cell level. Loss of Bmx preserved cardiac ejection fraction and decreased mortality following TAC. These findings are the first to demonstrate a necessary role for the Tec family of tyrosine kinases in the heart and reveal a novel regulator (Bmx) of pressure overload–induced hypertrophic growth.


Key Words: tyrosine kinase • cardiac hypertrophy • signal transduction